"Methodist Hospital Texsan has deep roots as one of South Texas’s premier heart and orthopedic hospitals. The facility excels in advanced cardiovascular services and is home to the Joint Replacement Academy and The Center for Spine, offering advanced technology and leading clinical results in the industry. Methodist Hospital Texsan’s convenient location and boutique atmosphere proudly offers an intimate and personal care experience to San Antonians."

During the past decade, Methodist Texsan Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Texsan Hospital" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored and "Biosense Webster, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Texsan Hospital" #1 collaborator was "Centers for Disease Control and Prevention" with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Rush University" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Texsan Hospital" are "Coronary Artery Disease" (12 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Stenosis" (2 trials), "Atherosclerosis" (1 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "Methodist Texsan Hospital" in a lesser frequency.

Most popular intervention types in "Methodist Texsan Hospital" are "Device" (12 trials) and "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "PROMUS Element Coronary Stent System" (3 trials), "Aspirin" (2 trials), "Thienopyridine" (2 trials), "Absorb BVS" (1 trials) and "Arm 1. Routine Care (Mupirocin/CHG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Texsan Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Texsan Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Methodist Texsan Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Texsan Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".